Advertisement

More articles from Cancer Therapy: Clinical

  • p53MVA and Gemcitabine for Ovarian Cancer
    Nicola R. Hardwick, Paul Frankel, Christopher Ruel, Julie Kilpatrick, Weimin Tsai, Ferdynand Kos, Teodora Kaltcheva, Lucille Leong, Robert Morgan, Vincent Chung, Raechelle Tinsley, Melissa Eng, Sharon Wilczynski, Joshua D.I. Ellenhorn, Don J. Diamond, Mihaela Cristea
    Clinical Cancer Research Mar 2018, 24 (6) 1315-1325; DOI: 10.1158/1078-0432.CCR-17-2709
  • Phase I Trial of M7824
    Julius Strauss, Christopher R. Heery, Jeffrey Schlom, Ravi A. Madan, Liang Cao, Zhigang Kang, Elizabeth Lamping, Jennifer L. Marté, Renee N. Donahue, Italia Grenga, Lisa Cordes, Olaf Christensen, Lisa Mahnke, Christoph Helwig, James L. Gulley
    Clinical Cancer Research Mar 2018, 24 (6) 1287-1295; DOI: 10.1158/1078-0432.CCR-17-2653
  • CART Immunotherapy in Treating EGFR+ Advanced BTCs
    Yelei Guo, Kaichao Feng, Yang Liu, Zhiqiang Wu, Hanren Dai, Qingming Yang, Yao Wang, Hejin Jia, Weidong Han
    Clinical Cancer Research Mar 2018, 24 (6) 1277-1286; DOI: 10.1158/1078-0432.CCR-17-0432
  • EBV-Based Antibody Risk Signature and NPC Early Detection
    Anna E. Coghill, Ruth M. Pfeiffer, Carla Proietti, Wan-Lun Hsu, Yin-Chu Chien, Lea Lekieffre, Lutz Krause, Andy Teng, Jocelyn Pablo, Kelly J. Yu, Pei-Jen Lou, Cheng-Ping Wang, Zhiwei Liu, Chien-Jen Chen, Jaap Middeldorp, Jason Mulvenna, Jeff Bethony, Allan Hildesheim, Denise L. Doolan
    Clinical Cancer Research Mar 2018, 24 (6) 1305-1314; DOI: 10.1158/1078-0432.CCR-17-1929
  • Axitinib in Nasopharyngeal Carcinoma
    Edwin P. Hui, Brigette B. Y. Ma, Herbert H. F. Loong, Frankie Mo, Leung Li, Ann D. King, Ki Wang, Anil T. Ahuja, Charles M. L. Chan, Connie W. C. Hui, Chi H. Wong, Anthony T. C. Chan
    Clinical Cancer Research Mar 2018, 24 (5) 1030-1037; DOI: 10.1158/1078-0432.CCR-17-1667
  • Multi-institutional Profiling of Lung Adenocarcinomas
    Dara L. Aisner, Lynette M. Sholl, Lynne D. Berry, Michael R. Rossi, Heidi Chen, Junya Fujimoto, Andre L. Moreira, Suresh S. Ramalingam, Liza C. Villaruz, Gregory A. Otterson, Eric Haura, Katerina Politi, Bonnie Glisson, Jeremy Cetnar, Edward B. Garon, Joan Schiller, Saiama N. Waqar, Lecia V. Sequist, Julie Brahmer, Yu Shyr, Kelly Kugler, Ignacio I. Wistuba, Bruce E. Johnson, John D. Minna, Mark G. Kris, Paul A. Bunn, David J. Kwiatkowski for the LCMC2 investigators
    Clinical Cancer Research Mar 2018, 24 (5) 1038-1047; DOI: 10.1158/1078-0432.CCR-17-2289
  • Ipilimumab plus Lenalidomide after HSCT in Lymphoma
    Issa F. Khouri, Irina Fernandez Curbelo, Francesco Turturro, Elias J. Jabbour, Denái R. Milton, Roland L. Bassett, Luis M. Vence, James P. Allison, Alison M. Gulbis, Padmanee Sharma
    Clinical Cancer Research Mar 2018, 24 (5) 1011-1018; DOI: 10.1158/1078-0432.CCR-17-2777
  • NY-ESO-1 Vaccination with Decitabine in MDS
    Elizabeth A. Griffiths, Pragya Srivastava, Junko Matsuzaki, Zachary Brumberger, Eunice S. Wang, Justin Kocent, Austin Miller, Gregory W. Roloff, Hong Yuen Wong, Benjamin E. Paluch, Linda G. Lutgen-Dunckley, Brandon L. Martens, Kunle Odunsi, Adam R. Karpf, Christopher S. Hourigan, Michael J. Nemeth
    Clinical Cancer Research Mar 2018, 24 (5) 1019-1029; DOI: 10.1158/1078-0432.CCR-17-1792
  • Hereditary Medullary Thyroid Cancer Treated with Vandetanib
    Ira L. Kraft, Srivandana Akshintala, Yuelin Zhu, Haiyan Lei, Claudia Derse-Anthony, Eva Dombi, Seth M. Steinberg, Maya Lodish, Steven G. Waguespack, Oxana Kapustina, Elizabeth Fox, Frank M. Balis, Maria J. Merino, Paul S. Meltzer, John W. Glod, Jack F. Shern, Brigitte C. Widemann
    Clinical Cancer Research Feb 2018, 24 (4) 753-765; DOI: 10.1158/1078-0432.CCR-17-2101
  • Phase I Trial of Veliparib and Weekly Topotecan
    Andrea E. Wahner Hendrickson, Michael E. Menefee, Lynn C. Hartmann, Harry J. Long, Donald W. Northfelt, Joel M. Reid, Felix Boakye-Agyeman, Olumide Kayode, Karen S. Flatten, Maria I. Harrell, Elizabeth M. Swisher, Guy G. Poirer, Daniel Satele, Jake Allred, Janet L. Lensing, Alice Chen, Jiuping Ji, Yiping Zang, Charles Erlichman, Paul Haluska, Scott H. Kaufmann
    Clinical Cancer Research Feb 2018, 24 (4) 744-752; DOI: 10.1158/1078-0432.CCR-17-1590

Pages